Toxicity in RO+ MS-LCH patients
| Arm . | Total evaluable RO+ patients . | Toxicity grade (% of patients) . | ||||
|---|---|---|---|---|---|---|
| 0 (none) . | 1 . | 2 . | 3* . | 4* . | ||
| A | 109 | 43 | 9 | 17 | 19 | 11 |
| B | 112 | 37 | 4 | 13 | 29 | 18 |
| Ratio (Arm B/Arm A) | 0.9 | 0.4 | 0.8 | 1.5 | 1.6 | |
| Arm . | Total evaluable RO+ patients . | Toxicity grade (% of patients) . | ||||
|---|---|---|---|---|---|---|
| 0 (none) . | 1 . | 2 . | 3* . | 4* . | ||
| A | 109 | 43 | 9 | 17 | 19 | 11 |
| B | 112 | 37 | 4 | 13 | 29 | 18 |
| Ratio (Arm B/Arm A) | 0.9 | 0.4 | 0.8 | 1.5 | 1.6 | |
Grade 3 and 4 toxicity, Arm B vs Arm A, P = .019.